Cartilaginous - ClinicalTrials.gov

A Randomized, Controlled, Comparative, Single-blinded, Multi-center Study Evaluating JointRep® and Microfracture in Repair of Focal Articular Cartilage Lesions on the Femoral Condyle or Trochlea, The JMAC Trial.

The JMAC study, a multinational multicenter Randomized Controlled Trial, is designed to determine the effectiveness and safety of JointRepu00ae, a second-generation chitosan-based hydrogel for cartilage repair, and to determine the quality and safety of cartilage repair. A total of 185 subjects will be randomized 2:1 to either Microfracture Plus JointRep U00ae or Microfracture alone. The new tissue quality will also be measured by structurally based and blindly measured T2; the upper and lower half of the new tissue T2 test will show the degree of stratification of the new cartilaginous tissue. A semiquantitative MOCART-2 blinded review will also be carried out.

Source link: https://clinicaltrials.gov/ct2/show/NCT04840147

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions